SEC Form 4 · accession 0001235802-18-000163
Wright Medical Group N.V. · WMGI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin C Oboyle
Director
Period of report
Nov 12, 2018
Accepted (ET)
Nov 14, 2018 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492658
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value EUR 0.03 per shareF2,F3 | Nov 12, 2018 | M | 12,740 | $22.50 | A | 35,130 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF4,F2 | Nov 12, 2018 | S | 12,740 | $30.1437 | D | 22,390 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF2 | Nov 13, 2018 | M | 4,537 | $22.50 | A | 26,927 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF5,F2 | Nov 13, 2018 | S | 4,537 | $30.0213 | D | 22,390 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F6 | $22.50 | Nov 12, 2018 | M | 12,740 | D | — | Jun 3, 2020 | Ordinary Shares | 12,740 | 37,260 | D |
| Stock Option (right to buy)F6 | $22.50 | Nov 13, 2018 | M | 4,537 | D | — | Jun 3, 2020 | Ordinary Shares | 4,537 | 32,723 | D |
Explanation of responses
- F1These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934.
- F2Includes 3,804 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.
- F3Total holdings were increased by one ordinary share due to a rounding error in the Form 4 report that was filed with the SEC on July 26, 2018.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.35, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.10, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.
- F6This option has fully vested.